Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Irritable Bowel Syndrome, June 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 87 articles: HTML format

Single Articles

1. YAN C, Hu C, Chen X, Jia X, et al
   Vitamin D improves irritable bowel syndrome symptoms: A meta-analysis.
   Heliyon. 2023;9:e16437.
   PubMed    
   Abstract available
   
   

2. YANG Q, Zhao Y, Zhao X, Sun S, et al
   Exploring the potential targets of Biling Weitong Granules on visceral hypersensitivity through integration of network pharmacology and in vivo analysis.
   J Ethnopharmacol. 2023 May 29:116701. doi: 10.1016/j.jep.2023.116701.
   PubMed    
   Abstract available
   
   

3. RIERA-CANALES C, Llanos-Chea A
   COVID-19 and the gastrointestinal tract in children.
   Curr Opin Pediatr. 2023 Jun 1. doi: 10.1097/MOP.0000000000001263.
   PubMed    
   Abstract available
   
   

4. MURTOMAKI K, Joutsa J, Mertsalmi T, Jaakkola E, et al
   Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease.
   Brain Behav. 2023 May 30:e3097. doi: 10.1002/brb3.3097.
   PubMed    
   Abstract available
   
   

5. PURSSELL H, Bennett L, Street O, Hanley KP, et al
   The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.
   Sci Rep. 2023;13:8769.
   PubMed    
   Abstract available
   
   

6. ZHAO XS, Shi LJ, Ning BL, Zhao ZM, et al
   Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: Phase I-II clinical trial.
   Immun Inflamm Dis. 2023;11:e857.
   PubMed    
   Abstract available
   
   

7. BRANT BJA, Yu Y, Omar AA, Jaramillo Polanco JO, et al
   Dietary monosodium glutamate increases visceral hypersensitivity in a mouse model of visceral pain.
   Neurogastroenterol Motil. 2023 Apr 27:e14596. doi: 10.1111/nmo.14596.
   PubMed    
   Abstract available
   
   

8. GAO X, Liu N, Hao YJ, Zhang XH, et al
   [Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome â…£ Diagnostic Criteria].
   Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54:574-578.
   PubMed    
   Abstract available
   
   

9. EL-SALHY M
   Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue.
   Neurogastroenterol Motil. 2023 May 29:e14621. doi: 10.1111/nmo.14621.
   PubMed    
   Abstract available
   
   

10. ANWER MK, Ahmed MM, Aldawsari MF, Iqbal M, et al
    Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box-Behnken Design, and Anti-Diarrheal Activity.
    Pharmaceutics. 2023;15:1460.
    PubMed    
    Abstract available
    
    

11. WILDER-SMITH CH, Materna A, Olesen SS
    Blueberries Improve Abdominal Symptoms, Well-Being and Functioning in Patients with Functional Gastrointestinal Disorders.
    Nutrients. 2023;15:2396.
    PubMed    
    Abstract available
    
    

12. GRECO N, Pisano A, Mezzatesta L, Pettinelli M, et al
    New Insights and Evidence on "Food Intolerances": Non-Celiac Gluten Sensitivity and Nickel Allergic Contact Mucositis.
    Nutrients. 2023;15:2353.
    PubMed    
    Abstract available
    
    

13. MORARIU ID, Avasilcai L, Vieriu M, Lupu VV, et al
    Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review.
    Nutrients. 2023;15:2295.
    PubMed    
    Abstract available
    
    

14. KIM JH, Lee Y, Kwon YS, Sohn JH, et al
    Clinical Implications of the Association between Respiratory and Gastrointestinal Disorders in Migraine and Non-Migraine Headache Patients.
    J Clin Med. 2023;12:3434.
    PubMed    
    Abstract available
    
    

15. TOMITA T, Fukui H, Okugawa T, Nakanishi T, et al
    Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn's Disease: A Prospective Pilot Study.
    J Clin Med. 2023;12:3368.
    PubMed    
    Abstract available
    
    

16. THOMPSON RE, Edmonds K, Dutch RE
    Specific Residues in the C-Terminal Domain of the Human Metapneumovirus Phosphoprotein Are Indispensable for Formation of Viral Replication Centers and Regulation of the Function of the Viral Polymerase Complex.
    J Virol. 2023;97:e0003023.
    PubMed    
    Abstract available
    
    

17. KREULEN IAM, de Jonge WJ, van den Wijngaard RM, van Thiel IAM, et al
    Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling.
    Mycopathologia. 2023 Jun 9. doi: 10.1007/s11046-023-00743.
    PubMed    
    Abstract available
    
    

18. VASHKEVICH K, Janiuk K, Maleki N
    A model for irritable bowel syndrome and anxiety comorbidities in relation to alcohol use disorders.
    Front Med (Lausanne). 2023;10:1161130.
    PubMed    
    Abstract available
    
    

19. GOLOB J, Rao K, Berinstein J, Chey W, et al
    The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers.
    medRxiv. 2023 May 17:2023.05.16.23290065. doi: 10.1101/2023.05.16.23290065.
    PubMed    
    Abstract available
    
    

20. SUGIHARA N, Okada Y, Tomioka A, Ito S, et al
    Probiotic Yeast from Miso Ameliorates Stress-Induced Visceral Hypersensitivity by Modulating the Gut Microbiota in a Rat Model of Irritable Bowel Syndrome.
    Gut Liver. 2023 Jun 9. doi: 10.5009/gnl220100.
    PubMed    
    Abstract available
    
    

21. ZAIB S, Hayat A, Khan I
    Probiotics and their beneficial health effects.
    Mini Rev Med Chem. 2023 Jun 8. doi: 10.2174/1389557523666230608163823.
    PubMed    
    Abstract available
    
    

22. TODOR TS, Fukudo S
    Systematic review and meta-analysis of calculating degree of comorbidity of irritable bowel syndrome with migraine.
    Biopsychosoc Med. 2023;17:22.
    PubMed    
    Abstract available
    
    

23. SONG G, Trujillo S, Fu Y, Shibi F, et al
    Transcutaneous electrical stimulation for gastrointestinal motility disorders.
    Neurogastroenterol Motil. 2023 Jun 8:e14618. doi: 10.1111/nmo.14618.
    PubMed    
    Abstract available
    
    

24. HOUSTON KD, Hartnett J, Rose SJ
    Investigating the association between the COVID-19 vaccination and incident gastrointestinal symptomology: A comprehensive dataset.
    Data Brief. 2023;48:109287.
    PubMed    
    Abstract available
    
    

25. KAMP K, Clark-Snustad K, Yoo L, Winders S, et al
    A Comprehensive Self-Management Intervention for Inflammatory Bowel Disease (CSM-IBD): Protocol for a Pilot Randomized Controlled Trial.
    JMIR Res Protoc. 2023;12:e46307.
    PubMed    
    Abstract available
    
    

26. GHOSH S, Sharma JVP
    Evaluation of the Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome in Conjunction With Clinical Examinations and Laboratory Investigations.
    Cureus. 2023;15:e38567.
    PubMed    
    Abstract available
    
    

27. ALKHOWAITER SS, Alshahrani AH, Almarzouqi HF, Alonazi GK, et al
    Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders.
    Front Pharmacol. 2023;14:1131354.
    PubMed    
    Abstract available
    
    

28. ZENG X, He J, Li X, Chen P, et al
    Clinical efficacy of one-finger meditation massage on IBS-C based on the "gut-brain axis" theory: study protocol for a randomized controlled trial.
    BMC Complement Med Ther. 2023;23:185.
    PubMed    
    Abstract available
    
    

29. KALLASSY J, Gagnon E, Rosenberg D, Silbart LK, et al
    Strains of Faecalibacterium prausnitzii and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice.
    BMJ Open Diabetes Res Care. 2023;11:e003101.
    PubMed    
    Abstract available
    
    

30. LANCSEK L, Faber S, Rutledge C, Maduro RS, et al
    A Randomized Trial Comparing Standard Treatment and Stress-Relieving Therapies to Improve Irritable Bowel Syndrome Symptoms.
    J Nurs Care Qual. 2023 Jun 2. doi: 10.1097/NCQ.0000000000000725.
    PubMed    
    Abstract available
    
    

31. WANG M, Xie X, Zhao S, Ma X, et al
    Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Front Immunol. 2023;14:1136343.
    PubMed    
    Abstract available
    
    

32. FAN X, Shi J, Liu Y, Zhang M, et al
    Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression.
    Int J Nanomedicine. 2023;18:2839-2853.
    PubMed    
    Abstract available
    
    

33. WANG L, Lei J, Zhao Z, Jia J, et al
    Therapeutic effects of paeoniflorin on irritable bowel syndrome in rats.
    J Vet Sci. 2023;24:e23.
    PubMed    
    Abstract available
    
    

34. XIONG P, Yang W
    The high prevalence and burden of irritable bowel syndrome among university students.
    Gen Hosp Psychiatry. 2023 May 24:S0163-8343(23)00086.
    PubMed    
    
    
    

35. STAUDACHER HM, Black CJ, Teasdale SB, Mikocka-Walus A, et al
    Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management.
    Nat Rev Gastroenterol Hepatol. 2023 Jun 2:1-15. doi: 10.1038/s41575-023-00794.
    PubMed    
    Abstract available
    
    

36. CHAND SP, Kuckel DP, Huecker MR, Robertson KD, et al
    Functional and evolutionary implications of protein and metal content of leafhopper brochosomes.
    Insect Biochem Mol Biol. 2023;157:103962.
    PubMed    
    Abstract available
    
    

37. KIM Y, Kim KH, Park J, Yoon HI, et al
    Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: Development of the clinically applicable model.
    Radiother Oncol. 2023;183:109617.
    PubMed    
    Abstract available
    
    

38. DUNCANSON K, Tikhe D, Williams GM, Talley NJ, et al
    Irritable bowel syndrome - controversies in diagnosis and management.
    Expert Rev Gastroenterol Hepatol. 2023.
    PubMed    
    Abstract available
    
    

39. KESZTHELYI D
    How to address work impairment in patients with disorders of the gut-brain interaction?
    United European Gastroenterol J. 2023 Jun 14. doi: 10.1002/ueg2.12429.
    PubMed    
    
    
    

40. ZHAO ZR, Wang YX, Xu FY, Zhang WC, et al
    [Herbal-moxa plaster for diarrhea type irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial].
    Zhongguo Zhen Jiu. 2023;43:617-21.
    PubMed    
    Abstract available
    
    

41. HEREKAR A, Shimoga D, Jehangir A, Shahsavari D, et al
    Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management.
    Clin Exp Gastroenterol. 2023;16:79-85.
    PubMed    
    Abstract available
    
    

42. ZHU N, Zhu L, Zhang X, Huang C, et al
    Triptolide attenuates irritable bowel syndrome via inhibiting ODC1.
    BMC Gastroenterol. 2023;23:202.
    PubMed    
    Abstract available
    
    

43. TOBIN CA, Hill C, Shkoporov AN
    Factors Affecting Variation of the Human Gut Phageome.
    Annu Rev Microbiol. 2023 Jun 12. doi: 10.1146/annurev-micro-032421-105754.
    PubMed    
    Abstract available
    
    

44. JENT S, Bez NS, Catalano L, Rogler G, et al
    The Efficacy of a Diet Low in Fermentable Oligo-, Di-, Monosaccharides, and Polyols in Irritable Bowel Syndrome Compared to Its "Real-world" Effectiveness: Protocol for a Systematic Review.
    JMIR Res Protoc. 2023;12:e41399.
    PubMed    
    Abstract available
    
    

45. ZHAI L, Yang W, Li D, Zhou W, et al
    Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome.
    J Pharm Pharm Sci. 2023;26:11225.
    PubMed    
    Abstract available
    
    

46. VANDENBERK B, Raj SR
    Remote Patient Monitoring: What Have We Learned and Where Are We Going?
    Curr Cardiovasc Risk Rep. 2023;17:103-115.
    PubMed    
    Abstract available
    
    

47. ZHANG S, Chen L, Feng B
    An anesthesia protocol for robust and repeatable measurement of behavioral visceromotor responses to colorectal distension in mice.
    Front Pain Res (Lausanne). 2023;4:1202590.
    PubMed    
    Abstract available
    
    

48. GUICE JL, Hollins MD, Farmar JG, Tinker KM, et al
    Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.
    Front Nutr. 2023;10:1129329.
    PubMed    
    Abstract available
    
    

49. ZHOU D, Liu X, Lan L, Yu W, et al
    Protective effects of Liupao tea against high-fat diet/cold exposure-induced irritable bowel syndrome in rats.
    Heliyon. 2023;9:e16613.
    PubMed    
    Abstract available
    
    

50. XU Y, Yao R, Zhao W, Zhu J, et al
    Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome.
    Heliyon. 2023;9:e16544.
    PubMed    
    Abstract available
    
    

51. KHASAWNEH M, Craig OF, Gracie DJ, Black CJ, et al
    A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care.
    Clin Gastroenterol Hepatol. 2023 Jun 9:S1542-3565(23)00444.
    PubMed    
    Abstract available
    
    

52. CARPINELLI L, Savarese G, Pascale B, Milano WD, et al
    Gut-Brain Interaction Disorders and Anorexia Nervosa: Psychopathological Asset, Disgust, and Gastrointestinal Symptoms.
    Nutrients. 2023;15:2501.
    PubMed    
    Abstract available
    
    

53. LUNDERVOLD AJ, Hillestad EMR, Lied GA, Billing J, et al
    Assessment of Self-Reported Executive Function in Patients with Irritable Bowel Syndrome Using a Machine-Learning Framework.
    J Clin Med. 2023;12:3771.
    PubMed    
    Abstract available
    
    

54. FU Y, Waghray N, Fass R, Song G, et al
    Diagnostic Implications of Irritable Bowel Syndrome Is an Independent Risk Factor for Undergoing Surgical Interventions in Patients with Inflammatory Bowel Disease.
    Diagnostics (Basel). 2023;13:1901.
    PubMed    
    Abstract available
    
    

55. BALTA-FOIX R, Serrano-Adrover C, Lopez-Cano A, Gifre-Renom L, et al
    Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria.
    Microb Cell Fact. 2023;22:111.
    PubMed    
    Abstract available
    
    

56. FURGALA A, Ciesielczyk K, Przybylska-Felus M, Jablonski K, et al
    Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
    Sci Rep. 2023;13:9420.
    PubMed    
    Abstract available
    
    

57. CUI W, Chen M, Yang Y, Cai M, et al
    Applications of 1993 single nucleotide polymorphism loci in forensic pairwise kinship identifications and inferences.
    Forensic Sci Int Genet. 2023;65:102889.
    PubMed    
    Abstract available
    
    

58. QI WX, Wang X, Li C, Li S, et al
    Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
    Thorac Cancer. 2023;14:1556-1566.
    PubMed    
    Abstract available
    
    

59. ZHANG W, Qiu L, Tang F, Li H, et al
    Affective or cognitive interpersonal emotion regulation in couples: an fNIRS hyperscanning study.
    Cereb Cortex. 2023;33:7960-7970.
    PubMed    
    Abstract available
    
    

60. VARNEY J, Gibson P, Muir J
    Interpreting FODMAP content of foods in clinical practice.
    Rev Esp Enferm Dig. 2023;115:337-338.
    PubMed    
    Abstract available
    
    

61. ZHU H, Zhang Y, Du S, Wang H, et al
    Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS.
    Front Med (Lausanne). 2023;10:1183484.
    PubMed    
    Abstract available
    
    

62. LATOUR P, Louis E
    [Functional colopathy : still relevant ? Let's move to irritable bowel syndrome].
    Rev Med Liege. 2023;78.
    PubMed    
    Abstract available
    
    

63. GILHEANEY O, Chadwick A
    The Prevalence and Nature of Eating and Swallowing Problems in Adults with Fibromyalgia: A Systematic Review.
    Dysphagia. 2023 Jun 22. doi: 10.1007/s00455-023-10597.
    PubMed    
    Abstract available
    
    

64. SUN P, Lin W, Weng Y, Gong J, et al
    Spinal Cathepsin S promotes visceral hypersensitivity via FKN/CX3CR1/p38 MAPK signaling pathways.
    Mol Pain. 2023;19:17448069231179118.
    PubMed    
    Abstract available
    
    

65. HALKJAER SI, Lo B, Cold F, Hojer Christensen A, et al
    Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    World J Gastroenterol. 2023;29:3185-3202.
    PubMed    
    Abstract available
    
    

66. THOMAS DUPONT P, Izaguirre-Hernandez IY, Remes-Troche JM
    Contribution of MicroRNAs in the Development of Irritable Bowel Syndrome Symptoms.
    J Gastrointestin Liver Dis. 2023;32:230-240.
    PubMed    
    Abstract available
    
    

67. ZHANG D, Chen C, Xie Y, Zeng F, et al
    Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study.
    BMC Infect Dis. 2023;23:422.
    PubMed    
    Abstract available
    
    

68. AXELSSON E, Kern D, Hedman-Lagerlof E, Lindfors P, et al
    Psychological treatments for irritable bowel syndrome: a comprehensive systematic review and meta-analysis.
    Cogn Behav Ther. 2023 Jun 21:1-20. doi: 10.1080/16506073.2023.2225745.
    PubMed    
    Abstract available
    
    

69. JAGARE L, Rozenberga M, Silamikelis I, Ansone L, et al
    Metatranscriptome analysis of blood in healthy individuals and irritable bowel syndrome patients.
    J Med Microbiol. 2023;72.
    PubMed    
    Abstract available
    
    

70. CASH BD, Sharma A, Walker A, Laitman AP, et al
    Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation.
    Neurogastroenterol Motil. 2023 Jun 18:e14632. doi: 10.1111/nmo.14632.
    PubMed    
    Abstract available
    
    

71. ROGER AH, Gudleski GD, Quigley BM, Zvolensky MJ, et al
    Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach.
    Behav Ther. 2023;54:623-636.
    PubMed    
    Abstract available
    
    

72. FORD CK
    Nutrition Considerations in Patients with Functional Diarrhea.
    Curr Gastroenterol Rep. 2023 Jun 17. doi: 10.1007/s11894-023-00878.
    PubMed    
    Abstract available
    
    

73. LIU N, Li J, Wang Y, Zhang S, et al
    Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    J Ethnopharmacol. 2023 Jun 14:116672. doi: 10.1016/j.jep.2023.116672.
    PubMed    
    Abstract available
    
    

74. THIELE T, Baggio F, Prahauser B, Ruiz Subira A, et al
    Reptarenavirus S Segment RNA Levels Correlate with the Presence of Inclusion Bodies and the Number of L Segments in Snakes with Reptarenavirus Infection-Lessons Learned from a Large Breeding Colony.
    Microbiol Spectr. 2023;11:e0506522.
    PubMed    
    Abstract available
    
    

75. JIANG C, Wang K, Yan L, Yao H, et al
    Predicting the survival of patients with pancreatic neuroendocrine neoplasms using deep learning: A study based on Surveillance, Epidemiology, and End Results database.
    Cancer Med. 2023;12:12413-12424.
    PubMed    
    Abstract available
    
    

76. GAO RL, Xu B, Sun Z, Guan C, et al
    First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial.
    EuroIntervention. 2023;19:222-231.
    PubMed    
    Abstract available
    
    

77. CHUAH KH, Black CJ, Tee V, Lim SZ, et al
    A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care.
    Aliment Pharmacol Ther. 2023 Jun 1. doi: 10.1111/apt.17567.
    PubMed    
    Abstract available
    
    

78. WILSON B, Kanno T, Slater R, Rossi M, et al
    Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023 Jun 14. doi: 10.1111/apt.17609.
    PubMed    
    Abstract available
    
    

79. LUO Y, Jodorkovsky D, Singh P, Keefer LA, et al
    Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023;58:137-138.
    PubMed    
    
    
    

80. DAI C, Huang YH, Jiang M
    Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023;58:126-127.
    PubMed    
    
    
    

81. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome-authors' reply.
    Aliment Pharmacol Ther. 2023;58:139-140.
    PubMed    
    
    
    

82. MARASCO G, Maida M, Cremon C, Barbaro MR, et al
    Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome-Authors' reply.
    Aliment Pharmacol Ther. 2023;58:128-129.
    PubMed    
    
    
    

83. BALLOU S, Singh P, Nee J, Rangan V, et al
    Prevalence and Associated Factors of Bloating: Results from the Rome Foundation Global Epidemiology Study.
    Gastroenterology. 2023 Jun 12:S0016-5085(23)00826.
    PubMed    
    Abstract available
    
    

84. MOHAN BP, Loganathan P, Khan SR, Garg G, et al
    Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Indian J Gastroenterol. 2023 May 29. doi: 10.1007/s12664-023-01373.
    PubMed    
    Abstract available
    
    

85. BASHASHATI M, Schmulson MJ, Sarosiek I, Robles A, et al
    Disorders of Gut-brain Interaction on the US-Mexico Border: A Survey Using Rome IV Criteria.
    J Clin Gastroenterol. 2023 Jun 1. doi: 10.1097/MCG.0000000000001858.
    PubMed    
    Abstract available
    
    

86. FUTAGAMI S, Kessoku T, Kasai Y, Higurashi T, et al
    Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1111/jgh.16250.
    PubMed    
    Abstract available
    
    

87. CREED F
    Psychiatric disorders comorbid with general medical illnesses and functional somatic disorders: The Lifelines cohort study.
    PLoS One. 2023;18:e0286410.
    PubMed    
    Abstract available